论文部分内容阅读
目的:探讨沐舒坦雾化吸入治疗老年慢性支气管炎临床效果。方法:选取2013年10月-2014年10月十堰市太和医院武当山分院收治的老年慢性支气管炎患者84例,随机分为治疗组与对照组,各42例。对照组取常规治疗,治疗组加以沐舒坦雾化吸入治疗,对比两组患者的临床疗效。结果:治疗组总有效率为92.86%,明显高于对照组的80.95%,组间对比,差异有统计学意义(P<0.05)。结论:沐舒坦雾化吸入治疗老年慢性支气管炎临床疗效较高,减轻患者临床症状,促进病情康复。
Objective: To investigate the clinical efficacy of mucosolvan inhalation in the treatment of senile chronic bronchitis. Methods: Eighty-four elderly patients with chronic bronchitis admitted from October 2013 to October 2014 in Wudangshan Taihe Hospital of Shiyan were randomly divided into treatment group and control group, with 42 cases in each group. The control group to take conventional treatment, the treatment group were treated with mucosolvan inhalation, compared the clinical efficacy of two groups of patients. Results: The total effective rate of the treatment group was 92.86%, which was significantly higher than that of the control group (80.95%). There was significant difference between the two groups (P <0.05). Conclusion: Ambroxol inhalation inhalation treatment of senile chronic bronchitis clinical efficacy is higher, reduce the clinical symptoms and promote the recovery of the disease.